In an increasingly global marketplace, the challenge facing life sciences companies to harmonise their operations for maximum efficiency is greater than ever. This growth in commercial opportunities is paralleled by an explosion in communication channels between healthcare organisations and stakeholders. Jan van den Burg, Vice President of Commercial Strategy, is responsible for strategy and product marketing for Veeva Commercial Suite of Applications, focusing on the European market, and he shares his thoughts on the future of commercial innovation.
https://international-pharma.com/wp-content/uploads/2015/06/The-Future…pdf.pdf